Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency

Eur J Hum Genet. 2004 Aug;12(8):673-7. doi: 10.1038/sj.ejhg.5201190.


Mutations in the MYBPC3 gene, encoding the sarcomere protein myosin-binding protein C, are among the most frequent causes of autosomal dominant familial hypertrophic cardiomyopathy (FHC). We studied the frequency, type, and pathogenetic mechanism of MYBPC3 mutations in an unselected cohort of 81 FHC families, consecutively enrolled at a tertiary referral center. Nine mutations, six of which were novel, were found in 10 (12.3%) of the families using single-strand conformation polymorphism and DNA sequencing. A frameshift mutation in exon 2 clearly suggests that haploinsufficiency is a pathogenetic mechanism in FHC. In addition, splice site mutations in exon 6 and intron 31, a deletion in exon 13, and a nonsense mutation in exon 25, all lead to premature termination codons, most likely causing loss of function and haploinsufficiency. Furthermore, there were two missense mutations (D228N and A833 T) and one in-frame deletion (DeltaLys813). A considerable intrafamilial variation in phenotypic expression of MYBPC3-based FHC was noted, and we suggest that mutations influencing stability of mRNA could play a role in the variable penetrance and expressivity of the disease, perhaps via partial haploinsuffciency.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cardiomyopathy, Hypertrophic, Familial / genetics*
  • Child
  • DNA Mutational Analysis
  • DNA Primers
  • Denmark
  • Female
  • Humans
  • Lymphocytes / metabolism
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Phenotype*
  • Polymorphism, Single-Stranded Conformational
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism*
  • Sarcomeres / metabolism
  • Sequence Analysis, DNA


  • DNA Primers
  • RNA, Messenger